Loading…

Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats

The pharmacokinetic behaviour of albendazole sulfoxide (ABZSO) enantiomers was studied in rats after the oral administration of 10 mg/kg of rac-ABZSO, 5 mg/kg of (−)-ABZSO or 5 mg/kg of (+)-ABZSO. The disposition profiles of ABZSO enantiomers were similar in all treatments, but the calculated area u...

Full description

Saved in:
Bibliographic Details
Published in:The veterinary journal (1997) 2008-08, Vol.177 (2), p.297-299
Main Authors: Capece, Bettencourt P.S., Castells, Gloria, Godoy, Carlo, Arboix, Margarita, Cristòfol, Carles
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523
cites cdi_FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523
container_end_page 299
container_issue 2
container_start_page 297
container_title The veterinary journal (1997)
container_volume 177
creator Capece, Bettencourt P.S.
Castells, Gloria
Godoy, Carlo
Arboix, Margarita
Cristòfol, Carles
description The pharmacokinetic behaviour of albendazole sulfoxide (ABZSO) enantiomers was studied in rats after the oral administration of 10 mg/kg of rac-ABZSO, 5 mg/kg of (−)-ABZSO or 5 mg/kg of (+)-ABZSO. The disposition profiles of ABZSO enantiomers were similar in all treatments, but the calculated area under the curve for the (−)-ABZSO was higher in all cases compared with (+)-ABZSO. The results suggest that there is no chiral inversion of ABZSO enantiomers. After the administration of rac-ABZSO, 17.2% of the total dose was recovered in urine as albendazole ABZ (0.1%), albendazole sulfone ABZSO 2 (0.3%), albendazole 2-aminosulfone (ABZ-SO 2NH 2) (3.1%) and ABZSO (13.7%). The ratio (+) to (−) was similar in urine (1.6) and blood (1.7).
doi_str_mv 10.1016/j.tvjl.2007.04.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69224825</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1090023307001578</els_id><sourcerecordid>69224825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523</originalsourceid><addsrcrecordid>eNp9kM1u1TAQRq0K1JbCC7AAr9glHf_ESSQ2qKIUqVKRoGvLsSfgS2JfbN-K8vRNlCt1x2pGmvN9Gh1C3jKoGTB1uavLw26qOUBbg6yBsRNyzhrBK9637MWyQw8VcCHOyKucdwDQS8lPyRlrG6XaVpwT_-2XSbOx8bcPWLzNNI7UTAMGZ_7FCWk-TGP86x1SDCYUH2dMmRo3--BzwYSO-kCTsTh7S8eYZmqCoxn3JpmC0-N2Lvk1eTmaKeOb47wg99eff1zdVLd3X75efbqtrGi7UvV2QGHFAAPjTc8lInNd1ysnjbLCNE4pbCRw3slukcAZSG7V2A4rIRouLsiHrXef4p8D5qJnny1OkwkYD1mrnnPZ8WYB-QbaFHNOOOp98rNJj5qBXgXrnV4F61WwBqkXwUvo3bH9MMzoniNHowvwfgNGE7X5mXzW9985MLHIh5b164MfNwIXCw8ek87WY7DofEJbtIv-fx88ARVklwU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69224825</pqid></control><display><type>article</type><title>Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats</title><source>ScienceDirect Freedom Collection</source><creator>Capece, Bettencourt P.S. ; Castells, Gloria ; Godoy, Carlo ; Arboix, Margarita ; Cristòfol, Carles</creator><creatorcontrib>Capece, Bettencourt P.S. ; Castells, Gloria ; Godoy, Carlo ; Arboix, Margarita ; Cristòfol, Carles</creatorcontrib><description>The pharmacokinetic behaviour of albendazole sulfoxide (ABZSO) enantiomers was studied in rats after the oral administration of 10 mg/kg of rac-ABZSO, 5 mg/kg of (−)-ABZSO or 5 mg/kg of (+)-ABZSO. The disposition profiles of ABZSO enantiomers were similar in all treatments, but the calculated area under the curve for the (−)-ABZSO was higher in all cases compared with (+)-ABZSO. The results suggest that there is no chiral inversion of ABZSO enantiomers. After the administration of rac-ABZSO, 17.2% of the total dose was recovered in urine as albendazole ABZ (0.1%), albendazole sulfone ABZSO 2 (0.3%), albendazole 2-aminosulfone (ABZ-SO 2NH 2) (3.1%) and ABZSO (13.7%). The ratio (+) to (−) was similar in urine (1.6) and blood (1.7).</description><identifier>ISSN: 1090-0233</identifier><identifier>EISSN: 1532-2971</identifier><identifier>DOI: 10.1016/j.tvjl.2007.04.011</identifier><identifier>PMID: 17566773</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Administration, Oral ; albendazole ; Albendazole - administration &amp; dosage ; Albendazole - analogs &amp; derivatives ; Albendazole - blood ; Albendazole - chemistry ; Albendazole - pharmacokinetics ; Albendazole sulfoxide ; animal diseases ; animal models ; Animals ; Anthelmintics - administration &amp; dosage ; Anthelmintics - blood ; Anthelmintics - chemistry ; Anthelmintics - pharmacokinetics ; dosage ; Dose-Response Relationship, Drug ; drug evaluation ; drug formulations ; drug therapy ; Enantiomers ; Enantioselectivity ; helminthiasis ; Isomerism ; metabolites ; oral administration ; Pharmacokinetics ; Rats ; veterinary drugs ; veterinary medicine</subject><ispartof>The veterinary journal (1997), 2008-08, Vol.177 (2), p.297-299</ispartof><rights>2007 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523</citedby><cites>FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17566773$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Capece, Bettencourt P.S.</creatorcontrib><creatorcontrib>Castells, Gloria</creatorcontrib><creatorcontrib>Godoy, Carlo</creatorcontrib><creatorcontrib>Arboix, Margarita</creatorcontrib><creatorcontrib>Cristòfol, Carles</creatorcontrib><title>Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats</title><title>The veterinary journal (1997)</title><addtitle>Vet J</addtitle><description>The pharmacokinetic behaviour of albendazole sulfoxide (ABZSO) enantiomers was studied in rats after the oral administration of 10 mg/kg of rac-ABZSO, 5 mg/kg of (−)-ABZSO or 5 mg/kg of (+)-ABZSO. The disposition profiles of ABZSO enantiomers were similar in all treatments, but the calculated area under the curve for the (−)-ABZSO was higher in all cases compared with (+)-ABZSO. The results suggest that there is no chiral inversion of ABZSO enantiomers. After the administration of rac-ABZSO, 17.2% of the total dose was recovered in urine as albendazole ABZ (0.1%), albendazole sulfone ABZSO 2 (0.3%), albendazole 2-aminosulfone (ABZ-SO 2NH 2) (3.1%) and ABZSO (13.7%). The ratio (+) to (−) was similar in urine (1.6) and blood (1.7).</description><subject>Administration, Oral</subject><subject>albendazole</subject><subject>Albendazole - administration &amp; dosage</subject><subject>Albendazole - analogs &amp; derivatives</subject><subject>Albendazole - blood</subject><subject>Albendazole - chemistry</subject><subject>Albendazole - pharmacokinetics</subject><subject>Albendazole sulfoxide</subject><subject>animal diseases</subject><subject>animal models</subject><subject>Animals</subject><subject>Anthelmintics - administration &amp; dosage</subject><subject>Anthelmintics - blood</subject><subject>Anthelmintics - chemistry</subject><subject>Anthelmintics - pharmacokinetics</subject><subject>dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>drug evaluation</subject><subject>drug formulations</subject><subject>drug therapy</subject><subject>Enantiomers</subject><subject>Enantioselectivity</subject><subject>helminthiasis</subject><subject>Isomerism</subject><subject>metabolites</subject><subject>oral administration</subject><subject>Pharmacokinetics</subject><subject>Rats</subject><subject>veterinary drugs</subject><subject>veterinary medicine</subject><issn>1090-0233</issn><issn>1532-2971</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u1TAQRq0K1JbCC7AAr9glHf_ESSQ2qKIUqVKRoGvLsSfgS2JfbN-K8vRNlCt1x2pGmvN9Gh1C3jKoGTB1uavLw26qOUBbg6yBsRNyzhrBK9637MWyQw8VcCHOyKucdwDQS8lPyRlrG6XaVpwT_-2XSbOx8bcPWLzNNI7UTAMGZ_7FCWk-TGP86x1SDCYUH2dMmRo3--BzwYSO-kCTsTh7S8eYZmqCoxn3JpmC0-N2Lvk1eTmaKeOb47wg99eff1zdVLd3X75efbqtrGi7UvV2QGHFAAPjTc8lInNd1ysnjbLCNE4pbCRw3slukcAZSG7V2A4rIRouLsiHrXef4p8D5qJnny1OkwkYD1mrnnPZ8WYB-QbaFHNOOOp98rNJj5qBXgXrnV4F61WwBqkXwUvo3bH9MMzoniNHowvwfgNGE7X5mXzW9985MLHIh5b164MfNwIXCw8ek87WY7DofEJbtIv-fx88ARVklwU</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Capece, Bettencourt P.S.</creator><creator>Castells, Gloria</creator><creator>Godoy, Carlo</creator><creator>Arboix, Margarita</creator><creator>Cristòfol, Carles</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080801</creationdate><title>Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats</title><author>Capece, Bettencourt P.S. ; Castells, Gloria ; Godoy, Carlo ; Arboix, Margarita ; Cristòfol, Carles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Oral</topic><topic>albendazole</topic><topic>Albendazole - administration &amp; dosage</topic><topic>Albendazole - analogs &amp; derivatives</topic><topic>Albendazole - blood</topic><topic>Albendazole - chemistry</topic><topic>Albendazole - pharmacokinetics</topic><topic>Albendazole sulfoxide</topic><topic>animal diseases</topic><topic>animal models</topic><topic>Animals</topic><topic>Anthelmintics - administration &amp; dosage</topic><topic>Anthelmintics - blood</topic><topic>Anthelmintics - chemistry</topic><topic>Anthelmintics - pharmacokinetics</topic><topic>dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>drug evaluation</topic><topic>drug formulations</topic><topic>drug therapy</topic><topic>Enantiomers</topic><topic>Enantioselectivity</topic><topic>helminthiasis</topic><topic>Isomerism</topic><topic>metabolites</topic><topic>oral administration</topic><topic>Pharmacokinetics</topic><topic>Rats</topic><topic>veterinary drugs</topic><topic>veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Capece, Bettencourt P.S.</creatorcontrib><creatorcontrib>Castells, Gloria</creatorcontrib><creatorcontrib>Godoy, Carlo</creatorcontrib><creatorcontrib>Arboix, Margarita</creatorcontrib><creatorcontrib>Cristòfol, Carles</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The veterinary journal (1997)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Capece, Bettencourt P.S.</au><au>Castells, Gloria</au><au>Godoy, Carlo</au><au>Arboix, Margarita</au><au>Cristòfol, Carles</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats</atitle><jtitle>The veterinary journal (1997)</jtitle><addtitle>Vet J</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>177</volume><issue>2</issue><spage>297</spage><epage>299</epage><pages>297-299</pages><issn>1090-0233</issn><eissn>1532-2971</eissn><abstract>The pharmacokinetic behaviour of albendazole sulfoxide (ABZSO) enantiomers was studied in rats after the oral administration of 10 mg/kg of rac-ABZSO, 5 mg/kg of (−)-ABZSO or 5 mg/kg of (+)-ABZSO. The disposition profiles of ABZSO enantiomers were similar in all treatments, but the calculated area under the curve for the (−)-ABZSO was higher in all cases compared with (+)-ABZSO. The results suggest that there is no chiral inversion of ABZSO enantiomers. After the administration of rac-ABZSO, 17.2% of the total dose was recovered in urine as albendazole ABZ (0.1%), albendazole sulfone ABZSO 2 (0.3%), albendazole 2-aminosulfone (ABZ-SO 2NH 2) (3.1%) and ABZSO (13.7%). The ratio (+) to (−) was similar in urine (1.6) and blood (1.7).</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17566773</pmid><doi>10.1016/j.tvjl.2007.04.011</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1090-0233
ispartof The veterinary journal (1997), 2008-08, Vol.177 (2), p.297-299
issn 1090-0233
1532-2971
language eng
recordid cdi_proquest_miscellaneous_69224825
source ScienceDirect Freedom Collection
subjects Administration, Oral
albendazole
Albendazole - administration & dosage
Albendazole - analogs & derivatives
Albendazole - blood
Albendazole - chemistry
Albendazole - pharmacokinetics
Albendazole sulfoxide
animal diseases
animal models
Animals
Anthelmintics - administration & dosage
Anthelmintics - blood
Anthelmintics - chemistry
Anthelmintics - pharmacokinetics
dosage
Dose-Response Relationship, Drug
drug evaluation
drug formulations
drug therapy
Enantiomers
Enantioselectivity
helminthiasis
Isomerism
metabolites
oral administration
Pharmacokinetics
Rats
veterinary drugs
veterinary medicine
title Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A07%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20albendazole%20sulfoxide%20enantiomers%20administered%20in%20racemic%20form%20and%20separately%20in%20rats&rft.jtitle=The%20veterinary%20journal%20(1997)&rft.au=Capece,%20Bettencourt%20P.S.&rft.date=2008-08-01&rft.volume=177&rft.issue=2&rft.spage=297&rft.epage=299&rft.pages=297-299&rft.issn=1090-0233&rft.eissn=1532-2971&rft_id=info:doi/10.1016/j.tvjl.2007.04.011&rft_dat=%3Cproquest_cross%3E69224825%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c378t-9cbe3c3b0b125924ee1d8896d4a6c3a5d66e5402284801621042c6f7b6d4a3523%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69224825&rft_id=info:pmid/17566773&rfr_iscdi=true